Literature DB >> 15130995

Turning a blind eye: testing the success of blinding and the CONSORT statement.

Douglas G Altman, Kenneth F Schulz, David Moher.   

Abstract

Mesh：

Year:  2004        PMID： 15130995      PMCID： PMC406363          DOI： 10.1136/bmj.328.7448.1135-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

3.  The landscape and lexicon of blinding in randomized trials.

Authors:  Kenneth F Schulz; Iain Chalmers; Douglas G Altman
Journal:  Ann Intern Med       Date:  2002-02-05       Impact factor: 25.391

Review 4.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Authors:  Dean Fergusson; Kathleen Cranley Glass; Duff Waring; Stan Shapiro
Journal:  BMJ       Date:  2004-01-22

5.  Blinding in randomised trials: hiding who got what.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321
  5 in total
  8 in total

Review 1.  Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.

Authors:  Ann K Hopton; Hugh Macpherson
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

2.  A pre-trial evaluation of blinding for a Chinese herbal medicine trial.

Authors:  Shohreh Razavy; John Lee; Christopher Zaslawski
Journal:  Contemp Clin Trials Commun       Date:  2020-08-05

Review 3.  Acupuncture for peripheral joint osteoarthritis.

Authors:  Eric Manheimer; Ke Cheng; Klaus Linde; Lixing Lao; Junghee Yoo; Susan Wieland; Daniëlle Awm van der Windt; Brian M Berman; Lex M Bouter
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 4.  Nicotine replacement therapy versus control for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Samantha C Chepkin; Weiyu Ye; Chris Bullen; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

Review 5.  Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

Authors:  Isabelle Boutron; Lydia Guittet; Candice Estellat; David Moher; Asbjørn Hróbjartsson; Philippe Ravaud
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

6.  Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.

Authors:  Stephen Wright; Paul Duncombe; Douglas G Altman
Journal:  Trials       Date:  2012-10-09       Impact factor: 2.279

7.  Objectifying specific and nonspecific effects of acupuncture: a double-blinded randomised trial in osteoarthritis of the knee.

Authors:  Max Karner; Frank Brazkiewicz; Andrew Remppis; Joachim Fischer; Oliver Gerlach; Wolfgang Stremmel; Shanmuga Velayutham Subramanian; Henry Johannes Greten
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

Review 8.  Acupuncture for hip osteoarthritis.

Authors:  Eric Manheimer; Ke Cheng; L Susan Wieland; Xueyong Shen; Lixing Lao; Menghu Guo; Brian M Berman
Journal:  Cochrane Database Syst Rev       Date:  2018-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.